| Selenocompound metabolism |
1.79 |
2.22e-1 |
11/17 (64.71%) |
MTR;SEPHS2;KYAT3;...
|
| Pancreatic secretion |
1.78 |
1.20e-1 |
87/102 (85.29%) |
CA2;SLC4A4;SLC12A2;...
|
| Proximal tubule bicarbonate reclamation |
1.77 |
1.01e-1 |
21/23 (91.3%) |
CA2;PCK2;SLC4A4;...
|
| Sulfur metabolism |
1.74 |
1.00e-1 |
9/10 (90%) |
SQOR;SELENBP1;TST;...
|
| Mineral absorption |
1.65 |
1.62e-1 |
48/60 (80%) |
MT1X;MT1G;FXYD2;...
|
| Nitrogen metabolism |
1.64 |
1.59e-1 |
16/17 (94.12%) |
CA2;CPS1;CA6;...
|
| ECM-receptor interaction |
1.63 |
1.42e-1 |
80/88 (90.91%) |
COL1A2;SDC4;COL6A3;...
|
| Salivary secretion |
1.63 |
1.31e-1 |
76/93 (81.72%) |
SLC12A2;MUC5B;ITPR2;...
|
| Taurine and hypotaurine metabolism |
1.63 |
1.20e-1 |
8/11 (72.73%) |
ADO;GGT1;GGT5
|
| Pyrimidine metabolism |
1.62 |
1.12e-1 |
40/56 (71.43%) |
NT5E;NME3;UPP1;...
|
| Complement and coagulation cascades |
1.58 |
1.37e-1 |
76/85 (89.41%) |
C1S;SERPINA1;CFH;...
|
| Protein digestion and absorption |
1.58 |
1.28e-1 |
78/103 (75.73%) |
COL1A2;PRSS3;COL6A3;...
|
| Ether lipid metabolism |
1.53 |
1.89e-1 |
32/49 (65.31%) |
CHPT1;ENPP2;PLPP3;...
|
| Pentose phosphate pathway |
1.53 |
1.77e-1 |
25/30 (83.33%) |
ALDOB;GPI;FBP1;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.50 |
2.03e-1 |
84/100 (84%) |
CXCL14;CXCL12;CXCL9;...
|
| Glycerophospholipid metabolism |
1.50 |
1.92e-1 |
71/98 (72.45%) |
CHPT1;PLPP3;MBOAT2;...
|
| Prostate cancer |
1.47 |
2.25e-1 |
93/97 (95.88%) |
MMP9;FGFR1;E2F2;...
|
| Primary immunodeficiency |
1.45 |
2.61e-1 |
33/38 (86.84%) |
CD40;TAP1;IGLL1;...
|
| Transcriptional misregulation in cancer |
1.43 |
2.87e-1 |
158/192 (82.29%) |
MMP9;CD40;LMO2;...
|
| Fatty acid elongation |
1.43 |
2.78e-1 |
19/27 (70.37%) |
ELOVL2;ACOT7;HACD2;...
|
| Staphylococcus aureus infection |
1.41 |
2.93e-1 |
72/95 (75.79%) |
C1S;CFH;C1R;...
|
| Mucin type O-glycan biosynthesis |
1.41 |
2.83e-1 |
20/36 (55.56%) |
GALNT7;GALNT6;GCNT1;...
|
| Fructose and mannose metabolism |
1.41 |
2.85e-1 |
30/33 (90.91%) |
SORD;ALDOB;FBP1;...
|
| Gastric acid secretion |
1.40 |
2.85e-1 |
63/76 (82.89%) |
CA2;ITPR2;ITPR3;...
|
| Collecting duct acid secretion |
1.40 |
2.78e-1 |
22/27 (81.48%) |
CA2;TCIRG1;ATP6V0C;...
|
| Phosphonate and phosphinate metabolism |
1.38 |
3.10e-1 |
5/6 (83.33%) |
CHPT1
|
| Bladder cancer |
1.37 |
3.18e-1 |
40/41 (97.56%) |
MMP9;FGFR3;E2F2;...
|
| NF-kappa B signaling pathway |
1.35 |
3.39e-1 |
90/104 (86.54%) |
CXCL12;CD40;VCAM1;...
|
| Arachidonic acid metabolism |
1.32 |
4.09e-1 |
48/61 (78.69%) |
PTGES;CYP4F3;PLAAT3;...
|
| alpha-Linolenic acid metabolism |
1.30 |
4.17e-1 |
17/25 (68%) |
PLAAT3;PLA2G4C;PLA2G1B;...
|
| Fc epsilon RI signaling pathway |
-1.37 |
2.50e-1 |
57/68 (83.82%) |
AKT3;IL13;NRAS;...
|
| Adrenergic signaling in cardiomyocytes |
-1.38 |
2.45e-1 |
130/150 (86.67%) |
PPP1CB;ATP2B4;ADCY7;...
|
| Measles |
-1.38 |
2.46e-1 |
133/139 (95.68%) |
IRF7;NFKB1;IRF9;...
|
| Chemical carcinogenesis |
-1.39 |
2.44e-1 |
186/281 (66.19%) |
STAT3;CYP2A6;FGF9;...
|
| Melanogenesis |
-1.39 |
2.47e-1 |
74/101 (73.27%) |
ADCY7;PLCB1;ADCY6;...
|
| TGF-beta signaling pathway |
-1.40 |
2.38e-1 |
81/94 (86.17%) |
FMOD;BMP4;BMP8A;...
|
| Acute myeloid leukemia |
-1.40 |
2.45e-1 |
66/67 (98.51%) |
ARAF;BRAF;NFKB1;...
|
| Huntington disease |
-1.42 |
2.32e-1 |
233/306 (76.14%) |
NDUFS6;MAP3K5;NDUFS3;...
|
| Prolactin signaling pathway |
-1.42 |
2.33e-1 |
66/70 (94.29%) |
NFKB1;SOCS5;GCK;...
|
| Pyruvate metabolism |
-1.45 |
1.97e-1 |
41/47 (87.23%) |
MDH1;DLD;PCK1;...
|
| PPAR signaling pathway |
-1.46 |
1.86e-1 |
66/74 (89.19%) |
DBI;APOA2;HMGCS1;...
|
| RIG-I-like receptor signaling pathway |
-1.47 |
1.93e-1 |
64/70 (91.43%) |
IRF7;NFKB1;ATG12;...
|
| Caffeine metabolism |
-1.47 |
2.03e-1 |
5/6 (83.33%) |
NAT1;CYP2A6;XDH;...
|
| AMPK signaling pathway |
-1.47 |
2.06e-1 |
106/120 (88.33%) |
AKT2;STRADA;G6PC3;...
|
| Endocytosis |
-1.48 |
1.90e-1 |
198/252 (78.57%) |
CAV3;RAB5A;CHMP7;...
|
| Tyrosine metabolism |
-1.49 |
2.02e-1 |
30/36 (83.33%) |
MAOB;DCT;TYR;...
|
| Hedgehog signaling pathway |
-1.49 |
2.03e-1 |
43/56 (76.79%) |
FBXW11;IHH;CDON;...
|
| Ribosome |
-1.50 |
2.11e-1 |
113/158 (71.52%) |
RPL26;RPL27;RPL6;...
|
| Salmonella infection |
-1.50 |
2.18e-1 |
198/249 (79.52%) |
MAP2K4;NFKB1;HSP90B1;...
|
| Legionellosis |
-1.50 |
2.33e-1 |
51/57 (89.47%) |
TNF;IL6;IL1B;...
|
| Sphingolipid signaling pathway |
-1.51 |
2.49e-1 |
106/119 (89.08%) |
FCER1A;TNF;PLCB1;...
|
| Tight junction |
-1.51 |
2.66e-1 |
130/169 (76.92%) |
ARPC1B;AMOTL2;RAP1A;...
|
| Prion disease |
-1.54 |
2.25e-1 |
209/273 (76.56%) |
SDHB;PRKACA;NDUFS1;...
|
| Cholesterol metabolism |
-1.58 |
1.89e-1 |
44/50 (88%) |
SCARB1;CETP;PLTP;...
|
| mRNA surveillance pathway |
-1.59 |
1.95e-1 |
71/98 (72.45%) |
RNPS1;NXF2;CLP1;...
|
| Pathogenic Escherichia coli infection |
-1.63 |
1.61e-1 |
152/197 (77.16%) |
NFKB1;LPAR2;MYO5C;...
|
| Chagas disease |
-1.65 |
1.60e-1 |
93/102 (91.18%) |
MAP2K4;GNAO1;NFKB1;...
|
| Colorectal cancer |
-1.66 |
1.88e-1 |
84/86 (97.67%) |
RPS6KB2;AKT3;GADD45B;...
|
| Protein processing in endoplasmic reticulum |
-1.69 |
1.82e-1 |
127/171 (74.27%) |
DNAJC3;EDEM1;HSPBP1;...
|
| Spliceosome |
-1.76 |
2.39e-1 |
101/150 (67.33%) |
SRSF3;DHX38;SNRPB2;...
|
